Neon Therapeutics Overview

  • Founded
  • 2013
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 71
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $67M
Latest Deal Amount
  • Investors
  • 4

Neon Therapeutics General Information

Description

Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted therapies, dedicated to transforming the treatment of cancer by directing the immune system towards neoantigens. The company's pipeline products are NEO-PV-01, NEO-PTC-01, and NEO-SV-01.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Acquirer
Primary Office
  • 40 Erie Street
  • Suite 110
  • Cambridge, MA 02139
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neon Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 06-May-2020 $67M 00000 0000 Completed Generating Revenue
3. IPO 27-Jun-2018 00000 00000 00000 Completed Generating Revenue
2. Early Stage VC (Series B) 05-Dec-2017 $106M $161M 00000 Completed Startup
1. Early Stage VC (Series A) 01-Oct-2015 $55M $55M 0000 Completed Startup
To view Neon Therapeutics’s complete valuation and funding history, request access »

Neon Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view Neon Therapeutics’s complete cap table history, request access »

Neon Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Neon Therapeutics Inc is a clinical-stage biopharmaceutical company. It is focused in the field of neoantigen-targeted t
Drug Discovery
Cambridge, MA
71 As of 2019
00000
000 0000-00-00
000000&0 00000

0000000

t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat
0000 000000000
San Diego, CA
00 As of 0000
00000
0000 0000-00-00
00000000 00000

000000 0

commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu f
0000000000000
South San Francisco, CA
000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Neon Therapeutics Competitors (50)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
BioAtla Formerly VC-backed San Diego, CA 00 00000 00000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000 00000
000000 00000000000 Corporation Plymouth Meeting, PA 000 000.00 00000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
00 00000000 Venture Capital-Backed Glasgow, United Kingdom 00 000.00 000000000000 000.00
You’re viewing 5 of 50 competitors. Get the full list »

Neon Therapeutics Executive Team (15)

Name Title Board Seat Contact Info
Hugh O'Dowd Chief Executive Officer & Board Member
You’re viewing 1 of 15 executive team members. Get the full list »

Neon Therapeutics Board Members (14)

Name Representing Role Since
Cary Pfeffer MD Self Chairman & Board Member 000 0000
Hugh O'Dowd Neon Therapeutics Chief Executive Officer & Board Member 000 0000
Robert Kamen Ph.D Self Board Member 000 0000
Robert Tepper MD Self Board Member 000 0000
Stephen Sherwin MD Self Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Neon Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neon Therapeutics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
ArrowMark Partners Asset Manager Minority 000 0000 000000 0
Casdin Capital Hedge Fund Minority 000 0000 000000 0
Clal Biotechnology Industries Venture Capital Minority 000 0000 000000 0
Hillhouse Capital Group PE/Buyout Minority 000 0000 000000 0
Nextech Invest Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 9 investors. Get the full list »